Loading clinical trials...
Loading clinical trials...
Effects Of Eltrombopag On Thrombocytopenia, Platelet Function and Bleeding In Patients With Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia.
Conditions
Interventions
Promacta
blood drawing in patients with WAS
+1 more
Locations
1
United States
Weill Cornell Medical College
New York, New York, United States
Start Date
June 1, 2009
Primary Completion Date
May 15, 2017
Completion Date
June 30, 2017
Last Updated
March 18, 2019
NCT07104565
NCT06533098
NCT07032792
NCT04645199
NCT07362199
NCT07362238
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions